New Research Compares Two Methods for Assessing Blocked Heart Arteries in Patients with Borderline Coronary Disease

A study published in the New England Journal of Medicine examines whether a non-invasive, imaging-based technique produces outcomes comparable to the established pressure-wire method when guiding treatment decisions for patients with intermediate coronary artery blockages.

—

What the FAST III Trial Is Asking

The New England Journal of Medicine has published findings from the FAST III trial, a study examining how doctors should assess intermediate coronary lesions — partial blockages in the heart’s arteries that sit in a clinical grey zone, neither clearly severe enough to treat nor clearly safe to leave alone.

According to the journal’s post, the central question the trial addresses is whether outcomes for patients who undergo percutaneous revascularisation — a procedure that opens narrowed arteries, typically via a stent inserted through a small incision in the wrist or groin — differ depending on which measurement technique guides the decision to intervene.

Two Techniques, One Critical Decision

The two approaches under comparison are pressure-wire–derived fractional flow reserve (FFR) and angiography-derived FFR. Both methods aim to answer the same question: is a given coronary narrowing actually restricting blood flow enough to cause the patient harm?

Pressure-wire FFR is the established standard. It involves threading a thin wire fitted with a pressure sensor directly into the coronary artery to measure blood flow across the lesion. Angiography-derived FFR, by contrast, calculates the same measurement using computational analysis of standard coronary angiography images — the X-ray pictures already taken during the procedure — without needing the additional wire.

The appeal of the angiography-derived approach is practical. It removes a procedural step, potentially reducing cost, time, and patient discomfort. But whether it delivers the same clinical outcomes has, according to the journal, remained unknown — which is precisely what FAST III sets out to determine.

Why This Question Matters

Intermediate lesions are common. Many patients undergoing coronary angiography will have at least one artery with a borderline narrowing, and the decision about whether to stent it or leave it carries real consequences either way. Unnecessary stenting carries procedural risks; leaving a flow-limiting lesion untreated can lead to chest pain or heart attack.

The FAST III findings are summarised in a Quick Take video produced by the New England Journal of Medicine, making the research accessible beyond specialist cardiology audiences.

What the Research Does Not Yet Tell Us

The journal’s post does not detail the trial’s specific results, patient numbers, follow-up period, or the direction of any difference — or equivalence — found between the two methods. Those details are contained within the full published paper.

—

Key Takeaways

• The FAST III trial compares angiography-derived FFR with pressure-wire–derived FFR for guiding treatment of intermediate coronary lesions
• The question of whether outcomes are comparable between the two methods was, according to the New England Journal of Medicine, previously unknown
• The research has been summarised in a Quick Take video by the journal for broader accessibility

—

What This Means for Kent Residents

Patients in Kent who have been diagnosed with coronary artery disease, or who are awaiting or recovering from a coronary angiography procedure, may find this research relevant to conversations with their cardiology team at hospitals including Maidstone and Tunbridge Wells NHS Trust or East Kent Hospitals University NHS Foundation Trust. If you have questions about how your coronary lesions are being assessed or what measurement techniques your clinical team uses, the right place to raise those questions is directly with your consultant cardiologist or GP — not on the basis of a single study summary. For urgent cardiac symptoms including chest pain, breathlessness, or pain radiating to the arm or jaw, call 999 immediately; for non-emergency health queries, NHS 111 is available around the clock.